| Infectious complications and NK cell depletion following daratumumab treatment of multiple myeloma H Nahi, M Chrobok, C Gran, J Lund, A Gruber, G Gahrton, P Ljungman, ... PloS one 14 (2), e0211927, 2019 | 118 | 2019 |
| Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma H Nahi, M Chrobok, S Meinke, C Gran, N Marquardt, G Afram, T Sutlu, ... Cell Reports Medicine 3 (2), 2022 | 47 | 2022 |
| Translocation (11; 14) in newly diagnosed multiple myeloma, time to reclassify this standard risk chromosomal aberration? C Gran, K Uttervall, J Borg Bruchfeld, A Wallblom, E Alici, G Gahrton, ... European journal of haematology, 2019 | 35 | 2019 |
| Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma K Uttervall, J Borg Bruchfeld, C Gran, G Wålinder, R Månsson, J Lund, ... European Journal of Haematology 103 (3), 247-254, 2019 | 25 | 2019 |
| Case Report: Treatment of light‐chain amyloidosis with daratumumab monotherapy in two patients C Gran, G Gahrton, E Alici, H Nahi European Journal of Haematology 100 (4), 386-388, 2018 | 23 | 2018 |
| Validation of a competitive ELISA assay for the quantification of human serum hepcidin G Dahlfors, P Stål, EC Hansson, P Bàràny, C Sisowath, L Onelöv, ... Scandinavian Journal of Clinical and Laboratory Investigation 75 (8), 652-658, 2015 | 21 | 2015 |
| Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real‐life outcomes of daratumumab treatment G Afram, C Gran, J Borg Bruchfeld, AK Wagner, A Hussain, E Alici, H Nahi European Journal of Haematology 105 (2), 196-202, 2020 | 20 | 2020 |
| Outcome of COVID‐19 in multiple myeloma patients in relation to treatment KH Susek, C Gran, HG Ljunggren, E Alici, H Nahi European journal of haematology 105 (6), 751-754, 2020 | 19 | 2020 |
| Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t (11; 14) H Nahi, M Kashif, M Klimkowska, M Karvouni, A Wallblom, C Gran, ... American journal of hematology 96 (8), 925-933, 2021 | 16 | 2021 |
| Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma - Improved Overall Survival in First Line Haematopoietic Stem Cell Transplantation - A Large … British journal of haematology, 2020 | 14 | 2020 |
| Rapid complete response to single-agent Bcl-2 inhibitor venetoclax in a heart-transplanted patient with triple refractory immunoglobulin light-chain amyloidosis C Gran, J Borg Bruchfeld, F Ellin, H Nahi Acta Haematologica 143 (5), 500-503, 2020 | 13 | 2020 |
| Absence of a common founder mutation in patients with cooccurring myelodysplastic syndrome and plasma cell disorder M Klimkowska, Y Nannya, C Gran, R Månsson, I Douagi, S Ogawa, ... Blood, The Journal of the American Society of Hematology 137 (9), 1260-1263, 2021 | 9 | 2021 |
| Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma C Gran, J Liwing, AK Wagner, A Verhoek, A Gezin, E Alici, H Nahi American Journal of Hematology 96 (1), 23-30, 2021 | 9 | 2021 |
| Involved free light chain: an early independent predictor of response and progression in multiple myeloma C Gran, G Afram, J Liwing, A Verhoek, H Nahi Leukemia & Lymphoma 62 (9), 2227-2234, 2021 | 7 | 2021 |
| Dynamic follow‐up of smoldering multiple myeloma identifies a subset of patients at high risk of progression C Gran, V Luong, JB Bruchfeld, J Liwing, G Afram, J Lund, S Usmani, ... American Journal of Hematology 96 (3), E63, 2020 | 6 | 2020 |
| Linked-read whole-genome sequencing resolves common and private structural variants in multiple myeloma L Peña-Pérez, N Frengen, J Hauenstein, C Gran, C Gustafsson, J Eisfeldt, ... Blood Advances 6 (17), 5009-5023, 2022 | 2 | 2022 |
| The role of complement and extracellular vesicles in the development of pulmonary embolism in severe COVID-19 cases G Dumitrescu, J Antovic, N Soutari, C Gran, A Antovic, K Al-Abani, J Grip, ... Plos one 19 (8), e0309112, 2024 | | 2024 |
| Tissue Factor Positive Extracellular Vesicles and Risk of Thromboembolism in Diffuse Large B-Cell Lymphoma: A Prospective Exploratory Study V Otasevic, C Gran, N Milic, V Vukovic, B Mihaljevic, J Fareed, ... Blood 140 (Supplement 1), 2823-2824, 2022 | | 2022 |
| CD38 Down-Regulation on Ex Vivo Activated and Expanded NK Cells for Cell Therapy Persists after Infusion H Nahi, M Chrobook, S Meinke, C Gran, N Marquardt, G Afram, T Sutlu, ... Blood 138, 4796, 2021 | | 2021 |
| Strategies to Assess and Improve Prognostication of Plasma Cell Disorders C Gran PQDT-Global, 2021 | | 2021 |
